BPaL regimen can cut time for treatment of drug-resistant TB

BPaL is a six-month, alloral, three-drug regimen that is used to treat people with highly drug-resistant forms of TB. It consists of the TB Alliance developed antibiotic pretomanid, along with two other antibiotics: bedaquiline and linezolid.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rtd2Iw
via IFTTT